2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2020-06-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3826 |
_version_ | 1826561119882313728 |
---|---|
author | Francois Mach Colin Baigent Alberico L. Catapano Konstantinos C. Koskinas Manuela Casula Lina Badimon M. John Chapman Guy G. De Backer Victoria Delgado Brian A. Ference Ian M. Graham Alison Halliday Ulf Landmesser Borislava Mihaylova Terje R. Pedersen Gabriele Riccardi Dimitrios J. Richter Marc S. Sabatine Marja-Riitta Taskinen Lale Tokgozoglu Olov Wiklund |
author_facet | Francois Mach Colin Baigent Alberico L. Catapano Konstantinos C. Koskinas Manuela Casula Lina Badimon M. John Chapman Guy G. De Backer Victoria Delgado Brian A. Ference Ian M. Graham Alison Halliday Ulf Landmesser Borislava Mihaylova Terje R. Pedersen Gabriele Riccardi Dimitrios J. Richter Marc S. Sabatine Marja-Riitta Taskinen Lale Tokgozoglu Olov Wiklund |
author_sort | Francois Mach |
collection | DOAJ |
description | The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) |
first_indexed | 2024-04-09T20:45:44Z |
format | Article |
id | doaj.art-85da4c90ec0e40e594dfee9db7ef0e09 |
institution | Directory Open Access Journal |
issn | 1560-4071 2618-7620 |
language | Russian |
last_indexed | 2025-03-14T09:27:07Z |
publishDate | 2020-06-01 |
publisher | «FIRMA «SILICEA» LLC |
record_format | Article |
series | Российский кардиологический журнал |
spelling | doaj.art-85da4c90ec0e40e594dfee9db7ef0e092025-03-02T11:42:51Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202020-06-0125510.15829/1560-4071-2020-382629022019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular riskFrancois Mach0Colin Baigent1Alberico L. Catapano2Konstantinos C. KoskinasManuela CasulaLina BadimonM. John ChapmanGuy G. De BackerVictoria DelgadoBrian A. FerenceIan M. GrahamAlison HallidayUlf LandmesserBorislava MihaylovaTerje R. PedersenGabriele RiccardiDimitrios J. RichterMarc S. SabatineMarja-Riitta TaskinenLale TokgozogluOlov WiklundGeneva University HospitalUniversity of OxfordUniversity of MilanThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)https://russjcardiol.elpub.ru/jour/article/view/3826guidelinesdyslipidaemiascholesteroltriglycerideslow-density lipoproteinshigh-density lipoproteinsapolipoprotein blipoprotein(a)lipoprotein remnantstotal cardiovascular risktreatment(lifestyle)treatment (drugs)treatment |
spellingShingle | Francois Mach Colin Baigent Alberico L. Catapano Konstantinos C. Koskinas Manuela Casula Lina Badimon M. John Chapman Guy G. De Backer Victoria Delgado Brian A. Ference Ian M. Graham Alison Halliday Ulf Landmesser Borislava Mihaylova Terje R. Pedersen Gabriele Riccardi Dimitrios J. Richter Marc S. Sabatine Marja-Riitta Taskinen Lale Tokgozoglu Olov Wiklund 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk Российский кардиологический журнал guidelines dyslipidaemias cholesterol triglycerides low-density lipoproteins high-density lipoproteins apolipoprotein b lipoprotein(a) lipoprotein remnants total cardiovascular risk treatment (lifestyle) treatment (drugs) treatment |
title | 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk |
title_full | 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk |
title_fullStr | 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk |
title_full_unstemmed | 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk |
title_short | 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk |
title_sort | 2019 esc eas guidelines for themanagement of dyslipidaemias lipid modification to reduce cardiovascular risk |
topic | guidelines dyslipidaemias cholesterol triglycerides low-density lipoproteins high-density lipoproteins apolipoprotein b lipoprotein(a) lipoprotein remnants total cardiovascular risk treatment (lifestyle) treatment (drugs) treatment |
url | https://russjcardiol.elpub.ru/jour/article/view/3826 |
work_keys_str_mv | AT francoismach 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT colinbaigent 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT albericolcatapano 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT konstantinosckoskinas 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT manuelacasula 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT linabadimon 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT mjohnchapman 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT guygdebacker 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT victoriadelgado 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT brianaference 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT ianmgraham 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT alisonhalliday 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT ulflandmesser 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT borislavamihaylova 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT terjerpedersen 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT gabrielericcardi 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT dimitriosjrichter 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT marcssabatine 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT marjariittataskinen 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT laletokgozoglu 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk AT olovwiklund 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk |